Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17317394 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL193365 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL7749147 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL385010 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL18604185 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL385721 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL7065072 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL2331938 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL383271 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE | |
| SCHEMBL2333180 | 1.00 | CHRM2 (0.44) | CHRM2ADRA2AADORA3CHRM1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040821-A | Wide-temperature-range wave-absorbing material and preparation method thereof | 河南大学 | 2025-05-27 | — | — | CN | claimed |
| WO-2025103343-A1 | MESH-SHAPED POROUS CO2-CAPTURING SOLUTION AND SEPARATION METHOD FOR CO2 GAS | 中国石油大学(北京) | 2025-05-22 | — | — | WO | claimed |
| CN-119823109-A | An electrochromic material electrochromic composition and electrochromic device | 吉林大学 | 2025-04-15 | — | — | CN | claimed |
| WO-2024251139-A9 | DISPLAY PANEL AND PREPARATION METHOD THEREFOR, AND TOUCH-CONTROL DISPLAY APPARATUS | 京东方科技集团股份有限公司 | 2025-04-10 | — | — | WO | claimed |
| CN-119215480-A | Polymer microextraction column for in-situ growth of MOF (metal oxide film) and preparation and application thereof | 福州大学 | 2024-12-31 | — | — | CN | claimed |
| WO-2024251139-A1 | DISPLAY PANEL AND PREPARATION METHOD THEREFOR, AND TOUCH-CONTROL DISPLAY APPARATUS | 京东方科技集团股份有限公司 | 2024-12-12 | — | — | WO | claimed |
| CN-118949073-A | Composition for treating lung cancer and preparation method thereof | 西安医学院第一附属医院 | 2024-11-15 | — | — | CN | claimed |
| CN-118788160-A | Fluorinated polyamide thin layer composite organic nanofiltration membrane and preparation method thereof | 浙江大学 | 2024-10-18 | — | — | CN | claimed |
| CN-115260993-B | MXene stable ionic liquid-based phase-change emulsion and preparation method thereof | 东莞理工学院 | 2024-06-07 | — | — | CN | claimed |
| CN-117720698-B | Temperature-resistant salt-resistant nano-crosslinked polymer microsphere and preparation method and application thereof | 山东聚星石油科技有限公司 | 2024-05-03 | — | — | CN | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| US-20060052493-A1 | Polyolefin that may be modified, e.g., chlorinated and/or maleinized, ionic liquid such as N-hexylpyridinium tetrafluoroborate, resin having a hydroxyl value of 5-20 5-200 mgKOH/g, and curing agent; coating films having sufficient electric conductivity without using electrically conducting pigment. | KANSAI PAINT CO., LTD. (JP) | 2006-03-09 | — | — | US | claimed |
| CN-1743391-A | Paint compositions | KANSAI PAINT CO LTD (JP) | 2006-03-08 | — | — | CN | claimed |
| WO-2005083829-A2 | PROTECTED ACTIVE METAL ELECTRODE AND BATTERY CELL STRUCTURES WITH NON-AQUEOUS INTERLAYER ARCHITECTURE | POLYPLUS BATTERY COMPANY (US) | 2005-09-09 | — | — | WO | claimed |
| US-20050175894-A1 | Prevents the active metal from deleterious reaction with the environment on the other (cathode) side of the impervious layer, which may include aqueous or non-aqueous liquid electrolytes (catholytes) and/or a variety electrochemically active materials, including liquid, solid and gaseous oxidizers | POLYPLUS BATTERY COMPANY | 2005-08-11 | — | — | US | claimed |
| WO-2005038962-A2 | IONICALLY CONDUCTIVE MEMBRANES FOR PROTECTION OF ACTIVE METAL ANODES AND BATTERY CELLS | POLYPLUS BATTERY COMPANY (US) | 2005-04-28 | — | — | WO | claimed |
| US-20040191617-A1 | Chemical resistance; anodes, cathodes; protective membrane coating | POLYPLUS BATTERY COMPANY | 2004-09-30 | — | — | US | claimed |
| US-20040005286-A1 | Organic salt conditioner, organic salt-containing composition, and uses thereof | L'OREAL (FR) | 2004-01-08 | — | — | US | claimed |
| US-6623659-B2 | Preparing purified olefins from a mixture including olefins and other hydrocarbons by complexing olefin with an olefin-complexing metal salt dissolved, dispersed or suspended in ionic liquid | CHEVRON U.S.A. INC. | 2003-09-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040005286-A1 | Organic salt conditioner, organic salt-containing composition, and uses thereof | KRT18, HCN4, PRKDC | CHRM2 3434/4885ADRA2A 4852/4885ADORA3 2626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.